CVE-2012-0504

N/A

Beschreibung

Unspecified vulnerability in the Java Runtime Environment (JRE) component in Oracle Java SE 7 Update 2 and earlier, and 6 Update 30 and earlier, allows remote attackers to affect confidentiality, integrity, and availability via unknown vectors related to Install and the Java Update mechanism.

CVE Details

CVSS v3.1 BewertungN/A

Veroffentlicht2/15/2012

Zuletzt geandert4/29/2026

Quellenvd

Honeypot-Sichtungen0

Betroffene Produkte

oracle:jdkoracle:jresun:jdksun:jre

Referenzen

http://marc.info/?l=bugtraq&m=133364885411663&w=2(secalert_us@oracle.com)

http://marc.info/?l=bugtraq&m=133847939902305&w=2(secalert_us@oracle.com)

http://marc.info/?l=bugtraq&m=134254866602253&w=2(secalert_us@oracle.com)

http://marc.info/?l=bugtraq&m=134254957702612&w=2(secalert_us@oracle.com)

http://secunia.com/advisories/48589(secalert_us@oracle.com)

http://www.oracle.com/technetwork/topics/security/javacpufeb2012-366318.html(secalert_us@oracle.com)

http://www.securityfocus.com/bid/52020(secalert_us@oracle.com)

https://oval.cisecurity.org/repository/search/definition/oval%3Aorg.mitre.oval%3Adef%3A14890(secalert_us@oracle.com)

http://marc.info/?l=bugtraq&m=133364885411663&w=2(af854a3a-2127-422b-91ae-364da2661108)

http://marc.info/?l=bugtraq&m=133847939902305&w=2(af854a3a-2127-422b-91ae-364da2661108)

http://marc.info/?l=bugtraq&m=134254866602253&w=2(af854a3a-2127-422b-91ae-364da2661108)

http://marc.info/?l=bugtraq&m=134254957702612&w=2(af854a3a-2127-422b-91ae-364da2661108)

http://secunia.com/advisories/48589(af854a3a-2127-422b-91ae-364da2661108)

http://www.oracle.com/technetwork/topics/security/javacpufeb2012-366318.html(af854a3a-2127-422b-91ae-364da2661108)

http://www.securityfocus.com/bid/52020(af854a3a-2127-422b-91ae-364da2661108)

https://oval.cisecurity.org/repository/search/definition/oval%3Aorg.mitre.oval%3Adef%3A14890(af854a3a-2127-422b-91ae-364da2661108)

IOC Korrelationen

Keine Korrelationen erfasst

This product uses data from the NVD API but is not endorsed or certified by the NVD.